RxDoctor Payments Data

Julie Mihalik

Family · Newton, NJNPI 1255958278

Payments from drug & device makers

$2,172in general payments, 2019–2025

Across 144 payments — averaging $15.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$625
  • GSK$245
  • AstraZeneca$242
  • Lilly USA, LLC$126
  • Astellas Pharma US Inc$83
  • Bayer$71
  • plus $780 from 26 others

What the payments were for

  • Food & beverage$2,172100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,172 in reported general payments places this provider in the 85th percentile of 2,692 family providers in New Jersey.

See all family providers in New Jersey

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban108$42,100
FarxigaDapagliflozin Propanediol38$17,901
MounjaroTirzepatide12$11,871
XareltoRivaroxaban30$11,158
Trelegy ElliptaFluticasone/Umeclidin/Vilanter16$10,951
JardianceEmpagliflozin16$10,414
Breo ElliptaFluticasone/Vilanterol14$7,225
Potassium Chloride86$7,114
EntrestoSacubitril/Valsartan18$6,190
Divalproex Sodium57$5,548
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog19$4,748
Enoxaparin Sodium37$3,266
Pantoprazole Sodium152$2,995
Atorvastatin Calcium175$2,599
Albuterol Sulfate HfaAlbuterol Sulfate35$2,060

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$51$42,100108 claims
GSKTrelegy Ellipta, Breo Ellipta$245$18,17630 claims
AstraZenecaFarxiga$242$17,90138 claims
Lilly USA, LLCMounjaro$126$11,87112 claims
Boehringer IngelheimJardiance$70$10,41416 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,692 family providers in New Jersey.

Other family in Newton

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →